Leadership built around a harder standard.

Patient experience must perform. Jumo Health's leaders are building the strategy, systems, and operating discipline required to make readiness measurable and clinical trial participation more durable.

The work is human. The accountability is operational.

Clinical trials ask patients and caregivers to make difficult decisions, absorb complex information, reorganize daily life, and sustain commitment under uncertainty. Leadership means treating those realities as execution variables rather than downstream surprises.

Jumo Health brings together clinical research, behavioral science, health literacy, human-centered design, data, technology, and commercialization around one mandate: prepare people better so trials perform more predictably.

Executive leadership.

Four leaders set the enterprise strategy, operating discipline, growth priorities, and financial accountability behind Jumo Health.

Chief Executive Officer

Brittany Erana

Brittany brings more than two decades of experience across global research operations, digital implementation, decentralized trials, and patient-first study design, including executive leadership roles at PPD and Thermo Fisher Scientific. That experience has shown her that patient-centered thinking cannot remain a principle stated in a strategy deck. It must shape how trials are designed, delivered, and measured. At Jumo, she is building patient readiness into the infrastructure of clinical research. She uses technology to reduce burden, connect execution to patients' lived reality, and turn better experiences into stronger enrollment, more durable retention, and a clearer path to completion.

Executive Vice President, Innovation & GTM

John Seaner

John brings 30 years of experience building categories, products, brands, and growth engines around emerging technology, including executive leadership roles at Medidata, conversationHEALTH, and Swoop. His work across AI, healthcare data, enterprise platforms, and decision science has centered on understanding why people act, then turning that understanding into systems businesses can scale. At Jumo, that perspective frames both innovation and go-to-market strategy. He is helping define the model clinical trials have been missing: patient readiness as measurable infrastructure for recruitment, retention, completion, and more credible forecasting.

Executive Vice President, Growth & Client Partnerships

Peter DuPrat

Peter brings more than 20 years of CRO, pharmaceutical, and healthcare growth experience, including executive leadership roles at Worldwide Clinical Trials, NuvoAir, Optum, and PPD. That experience frames a simple discipline at Jumo: understand the sponsor's problem before proposing the solution. He leads partnerships from the first executive conversation through deployment, measurement, and expansion, aligning readiness with the operational pressures sponsors must solve. His mandate is to build relationships strong enough to improve study performance, scale across portfolios, and earn a lasting place in how clients execute trials.

Chief Financial Officer

Linda Williams

Linda brings financial leadership experience across healthcare services, pharmaceutical development, and life-sciences commercialization, including executive leadership roles at IntegriChain, VenatoRx Pharmaceuticals, and Impax Laboratories. She has guided accounting operations, financial strategy, transaction diligence, and organizational scale through periods of growth and change. That experience frames her role at Jumo, where ambition must always meet accountability. Linda gives innovation an economic architecture: resources follow the work with the greatest value, expansion does not outrun execution, and patient-first investment is built to endure. She ensures Jumo's growth is disciplined, resilient, and worthy of the trust placed in it.

PRISM senior leadership.

Four disciplines govern the system: readiness orchestration, readiness intelligence, professional services, and behavioral science.

Head of Readiness Orchestration

Mackenzie McKinney

Mackenzie brings experience across global clinical research, digital trial implementation, site and patient experience, and patient-facing technologies, including senior leadership roles at Moderna, PPD, and Signant Health. She has led programs that connect patient voice with practical services, digital solutions, and the realities sites manage every day. At Jumo, that experience frames readiness orchestration: turning patient insight into education, guided prescreening, coordinated support, and site handoffs that patients can realistically sustain.

Head of Readiness Intelligence

David Budd

David brings global experience across life sciences research, market access, evidence strategy, health data, and commercialization, including senior leadership roles at Trinity Life Sciences and Ipsos. His career has focused on turning complex clinical and market signals into decisions leaders can act on. At Jumo, that discipline frames readiness intelligence: connecting protocol, clinical, behavioral, social, and operational data to reveal who is likely to advance, where completion risk is accumulating, and what intervention may change the outcome.

Head of Behavioral Science

Andy Proctor

Andy is a social and health psychologist and mixed-methods researcher whose work examines social connection, health behavior, psychophysiology, and human interaction with AI. His background includes senior leadership at OpenAI and research collaborations with Eventbrite and Brigham Young University. His work is grounded in a simple distinction: engagement is not the same as human flourishing. At Jumo, he applies that lens to the decisions patients and caregivers face, translating cognitive, emotional, social, and practical friction into experiences and interventions designed to support durable participation.

Head of Professional Services

Jennifer Crager

Jennifer brings more than two decades of experience across global research operations and clinical technology, including senior leadership roles at PPD Clinical Research, Thermo Fisher Scientific, ICON, and YPrime. She has led the strategy, design, and implementation of electronic outcomes, digital consent, virtual visits, sensors, customer support, quality, training, technical delivery, and project management. At Jumo, that breadth frames professional services: moving PRISM from strategy into governed deployment while aligning sponsors, sites, and delivery teams around measurable performance.

CORE senior leadership.

Four disciplines turn readiness strategy into patient understanding, global relevance, measurable value, and reliable delivery.

Senior Vice President, Strategy & Value

Mike Burton

Mike brings more than 25 years of experience across clinical operations, eClinical technology, digital health, and value engineering, including senior leadership roles at Veeva Systems, Tendo, Theorem Clinical Research, Wyeth, and ICON Clinical Research. At Jumo, he translates CORE's patient readiness model into operational and economic value sponsors can defend. His work connects protocol burden, comprehension, site friction, and completion risk to the measures that drive investment decisions, making patient experience an execution strategy rather than a discretionary service.

Vice President, Patient Readiness

Rebecca Schelkun

Rebecca combines public health expertise in epidemiology and biostatistics with senior leadership roles at Human Care Systems and research with the Philadelphia Department of Public Health. Her work across health equity, patient advocacy, pediatrics, rare disease, and clinical trial strategy has focused on one persistent challenge: information only works when people can use it. At Jumo, she leads patient readiness for CORE, turning protocol demands and lived experience into education, decision support, and expectation alignment designed to help patients participate with clarity.

Senior Vice President, EMEA

Sindy Nathan

Sindy brings more than a decade of experience across health literacy, patient education, strategic solutions, and international client partnerships, including senior leadership roles at Medikidz and Jumo Health. Her work has consistently translated complex clinical information into experiences patients and families can understand across cultures, languages, and health systems. She leads CORE across EMEA with a focus on regional relevance, global consistency, and the practical conditions required for education to strengthen participation.

Vice President, Delivery

Hayley Margolis

Hayley brings more than a decade of experience across patient-centered sciences, health economics and outcomes research, operations, solution architecture, and program delivery, including senior leadership roles at Lumanity, BresMed, and ICON plc. Her career has moved from understanding what matters to patients to building the operating systems that make evidence and patient experience work at scale. At Jumo, she leads CORE from readiness strategy through coordinated delivery, aligning teams, timelines, localization, quality, and client governance so every experience arrives consistently, accurately, and ready to perform across sites and markets.

Board of Directors.

Independent perspective, operating experience, and governance focused on building a durable patient-readiness company.

Chairman

Adam Cossman

Adam brings more than 25 years of experience across pharmaceutical commercialization, healthcare marketing, digital innovation, analytics, and company building, including executive leadership roles at Sentient, W2O Group, Real Chemistry, Ignite Health, and Temel. He founded Sentient as a healthcare-focused digital agency, led its sustained growth and sale to W2O Group, then helped integrate advertising, digital, media, technology, and analytics capabilities at enterprise scale. As Chairman, Adam applies that experience to Jumo's growth strategy, helping connect patient readiness innovation to market relevance, disciplined commercialization, and long-term enterprise value.

Director | Partner, Falfurrias Capital Partners

Joe Price

Joe brings financial leadership, operational strategy, investment experience, and board governance shaped by executive leadership roles at Bank of America, an earlier career at PricewaterhouseCoopers, and his work as a Partner at Falfurrias Capital Partners. At Bank of America, he served as President of Consumer and Small Business Banking, Chief Financial Officer, and Global Corporate and Investment Banking Risk Management Executive. He has also chaired the boards of Habitat for Humanity International and the University of North Carolina at Charlotte and served across a broad portfolio of growth companies. At Jumo, Joe brings financial discipline, pattern recognition, and a clear view of what responsible scale requires.

Director

Jackie Kent

Jackie brings more than 30 years of experience across clinical development, trial operations, clinical technology, product strategy, and customer success, including executive leadership roles at Eli Lilly and Medidata. During more than two decades at Eli Lilly, she supported information technology, clinical trial design and execution, and clinical supply planning. At Medidata, she served as Executive Vice President and Head of Product and later as Chief Customer Officer, leading teams responsible for product strategy, customer success, quality, education, and platform adoption. She also served as Chair of the Association of Clinical Research Organizations and on multiple industry boards. At Jumo, Jackie keeps innovation grounded in the realities of sponsors, sites, and patients.

The leadership mandate.

Three commitments govern how Jumo Health builds, advises, and operates.

Own readiness.

Make the patient conditions behind advancement, persistence, and completion visible before they become operational failure.

Protect patient choice.

Create the understanding, expectation alignment, and support people need to make an informed decision and sustain it.

Make performance durable.

Connect patient experience to screening quality, site efficiency, retention visibility, forecast confidence, and cost per completer.

Patient-centered leadership should change the operating result.

Empathy without execution remains an intention. Jumo Health's leadership team is accountable for turning insight into systems, education into readiness, and readiness into more durable clinical trial participation.

Frequently Asked Questions

Who is the CEO of Jumo Health?

Brittany Erana is the Chief Executive Officer of Jumo Health. She leads the company's strategy to make patient readiness an operational discipline across clinical trial recruitment, participation, and completion.

Who is on Jumo Health's executive leadership team?

Jumo Health's executive leadership team includes Brittany Erana, Chief Executive Officer; John Seaner, Executive Vice President of Innovation and GTM; Peter DuPrat, Executive Vice President of Growth and Client Partnerships; and Linda Williams, Chief Financial Officer.

Who leads PRISM at Jumo Health?

PRISM senior leadership includes Mackenzie McKinney, Head of Readiness Orchestration; David Budd, Head of Readiness Intelligence; Andy Proctor, Head of Behavioral Science; and Jennifer Crager, Head of Professional Services.

Who leads CORE at Jumo Health?

CORE senior leadership includes Mike Burton, Senior Vice President of Strategy and Value; Rebecca Schelkun, Vice President of Patient Readiness; Sindy Nathan, Senior Vice President of EMEA; and Hayley Margolis, Vice President of Delivery.

Who serves on the Jumo Health Board of Directors?

Jumo Health's Board of Directors includes Adam Cossman, Chairman; Joe Price, Partner at Falfurrias Capital Partners; and Jackie Kent, Director.

What experience does the Jumo Health leadership team bring?

The leadership team brings experience from organizations including PPD, Thermo Fisher Scientific, Medidata, conversationHEALTH, Swoop, Worldwide Clinical Trials, Moderna, Signant Health, Trinity Life Sciences, Ipsos, ICON, YPrime, Veeva Systems, Tendo, Theorem Clinical Research, Wyeth, Human Care Systems, Medikidz, Lumanity, and BresMed across digitally enabled clinical research, patient experience, behavioral science, healthcare innovation, data, AI, commercialization, and finance.

What is Jumo Health's leadership mandate?

Jumo Health's leadership is focused on making patient readiness an operational discipline so sponsors can improve participation quality, reduce preventable trial friction, and make completion more predictable.